Loading company…
Wuhan Greenovo manufactures biomedical materials for hemostasis and wound care.
Founded in 2012 and based in Wuhan, China, Wuhan Greenovo develops, produces, and sells biomedical materials for hemostasis and wound care. Its products serve areas including first aid, surgery, dentistry, cardiovascular care, and home care. The company was listed on the National Equities Exchange and Quotations in August 2017 under stock code 871920 and raised CNY 99.99 million in venture funding in October 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in